A Randomized, Controlled, Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients with Hepatic-Dominant Ocular Melanoma

Administered By

Awarded By

Contributors

Start/End

  • March 1, 2016 - February 28, 2022